MedScout, a revenue acceleration platform revolutionizing commercial operations for medtech and life sciences companies, recently announced its $10M growth round. Exbo Group provides MedScout with ongoing CFO and Controllership services.

The round was led by Fulcrum Equity Partners. Stage 2 Capital and LiveOak Ventures, existing investors, also provided key support.

MedScout plans to use the funding to keep building the AI capabilities med device teams need to hit their revenue goals. These AI agents translate commerical priorities into clear action for reps. It identifies the right targets, improving conversion rates and account expansion.